EQS-News: Cantourage Group SE / Key word(s): Research Update Montega AG includes Cantourage Group SE in its coverage with ‘Buy’ 20.10.2023 / 08:10 CET/CEST The issuer is solely responsible for the content of this announcement. Not for publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such publication or distribution would be unlawful. The important notices at the end of this press release should be observed. Montega AG includes Cantourage Group SE in its coverage with “Buy” Berlin, October 20, 2023 – Research house Montega AG, Hamburg, initiated coverage on Cantourage Group SE (hereinafter “Cantourage”, ISIN: DE000A3DSV01, www.cantourage.com/en) in a report published yesterday. Montega rates the Cantourage share with a “buy” recommendation and a price target of EUR 10.50. Further information is available at https://www.cantourage.com/en/investors/analysts. About Cantourage For further information: www.cantourage.com/en This announcement does not constitute a public offer or an advertisement for a public offer for sale of securities, in particular within the meaning of Regulation (EU) 2017/1129 (Prospectus Regulation). Press contact at Cantourage: 20.10.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Prenatal Folic Acid Supplements Tied to Lower Risk of Kawasaki Disease in Babies
Folic acid supplementation throughout pregnancy was correlated with a lower risk of early-onset Kawasaki disease in offspring, a Japanese observational study showed. In a propensity